Metastatic Colorectal Cancers Recruiting Phase 2 Trials for Durvalumab (DB11714)

Also known as: Colorectal Cancer Metastatic / Metastatic Colorectal Cancer / Metastatic Colorectal Cancer (MCRC) / Cancer - Metastatic Colorectal / Colorectal Cancer, Metastatic

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03435107Durvalumab for MSI-H or POLE Mutated Metastatic Colorectal CancerTreatment